External quality assurance (EQA) is crucial to monitor and improve the quality of biochemical genetic testing. ERNDIM (www.erndim.org), established in 1994, aims at reliable and standardized procedures for diagnosis, treatment and monitoring of inherited metabolic disease (IMD) by providing EQA schemes and educational activities. Currently, ERNDIM provides 16 different EQA schemes including quantitative schemes for various metabolite groups, and interpretive schemes such as diagnostic proficiency testing (DPT). DPT schemes focus on the ability of laboratories to correctly identify and interpret abnormalities in authentic urine samples across a wide range of IMDs. In the DPT schemes, six samples each year are distributed together with clinical information. Laboratories choose and perform the tests needed to reach a diagnosis. Data were collected on 345 samples, distributed to up to 105 laboratories worldwide. Diagnostic proficiency (the % of total points possible for all participating laboratories within a scheme for analysis and interpretation) ranged widely: amino acid disorders (n = 20), range 33%-100%, mean 84%; organic acid disorders (n = 35), range 14%-100%, mean 84%; lysosomal storage disorders (n = 13), range 20%-97%, mean 73%; purine/pyrimidine disorders (n = 9), range 37%-100%, mean 70%; miscellaneous disorders (n = 8), range 17%-100%, mean 65%; no IMD, range 65%-95%, mean 85%. When a sample with the same disorder was distributed in a subsequent survey, performance improved in 75 cases with no improvement seen in 32, suggesting overall improvement of performance. ERNDIM diagnostic proficiency testing is a valuable activity which can help to assess laboratory performance, identify methodological/technical challenges, be informative during quality audits and contribute to a better clinical appreciation of diagnostic uncertainty.

Department of Clinical Chemistry and Newborn Screening Sheffield Children's NHS Foundation Trust Sheffield UK

Department of Clinical Genetics Center for Lysosomal and Metabolic Diseases Erasmus University Medical Center Rotterdam The Netherlands

Department of Pediatrics and Inherited Metabolic Disorders General University Hospital Prague and 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Division of Inborn Errors of Metabolism Department of Biochemistry and Molecular Biology CHU de Lyon Lyon France

University Children's Hospital Basel University Children's Hospitals Zürich Basel and Zürich Switzerland

University Institute of Clinical Chemistry Inselspital Bern University Hospital University of Bern Bern Switzerland

Zobrazit více v PubMed

Ferreira CR, Rahman S, Keller M, Zschocke J. An international classification of inherited metabolic disorders (ICIMD). J Inherit Metab Dis. 2021;44:164‐177. PubMed PMC

Sciacovelli L, Secchiero S, Zardo L, Zaninotto M, Plebani M. External quality assessment: an effective tool for clinical governance in laboratory medicine. Clin Chem Lab Med. 2006;44(6):740‐749. PubMed

Hoffman GF. Selective screening for inborn errors of metabolism—past, present and future. Eur J Pediatr. 1994;153:2‐8. PubMed

Fowler B, Burlina A, Kozich V, Vianey‐Saban C. Quality of analytical performance in inherited metabolic disorders: the role of ERNDIM. J Inherit Metab Dis. 2008;31:680‐689. PubMed

Peters V, Bonham JR, Hoffmann GF, Scott C, Langhans CD. Qualitative urinary organic acid analysis: 10 years of quality assurance. J Inherit Metab Dis. 2016;39:683‐687. PubMed

Peters V, Garbade SF, Langhans CD, et al. Qualitative urinary organic acid analysis: methodological approaches and performance. J Inherit Metab Dis. 2008;31:690‐696. PubMed

Tan IK, Gajra B, Lim MSF. External proficiency testing programmes in laboratory diagnoses of inherited metabolic disorders. Ann Acad Med Singapore. 2006;35:688‐693. PubMed

Oglesbee D, Cowan TM, Pasquali M, et al. CAP/ACMG proficiency testing for biochemical genetics laboratories: a summary of performance. Genet Med. 2018;20:83‐90. PubMed PMC